Constellation Pharmaceuticals Inc (CNST)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
33.99 +0.02 (+0.06%) 07/14/21 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 33.99 unch (unch) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -126,357 | -85,550 | -59,925 | -35,377 | -34,533 |
| Depreciation Amortization | 496 | 60 | 562 | 474 | 203 |
| Accounts payable and accrued liabilities | 2,521 | 1,733 | 2,751 | 67 | 423 |
| Other Working Capital | -2,484 | 5,825 | 6,433 | 255 | 591 |
| Other Operating Activity | 14,400 | 5,684 | 1,356 | -3,005 | 541 |
| Operating Cash Flow | $-111,424 | $-72,248 | $-48,823 | $-37,586 | $-32,775 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -905 | -699 | -476 | -582 | -945 |
| Purchase Of Investment | -580,330 | -114,685 | N/A | 0 | N/A |
| Sale Of Investment | 372,334 | 65,775 | 0 | 0 | N/A |
| Investing Cash Flow | $-208,901 | $-49,609 | $-476 | $-582 | $-945 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 29,650 | 290 | 0 | 48 |
| Debt Repayment | -32,208 | N/A | -4,698 | -6,634 | -4,204 |
| Common Stock Issued | 184,702 | 312,072 | 56,110 | 55 | 60 |
| Other Financing Activity | 0 | -125 | 95,968 | 24,231 | 23,201 |
| Financing Cash Flow | $152,494 | $341,597 | $147,670 | $17,652 | $19,105 |
| Beginning Cash Position | 334,757 | 115,017 | 16,646 | 37,162 | 51,777 |
| End Cash Position | 166,926 | 334,757 | 115,017 | 16,646 | 37,162 |
| Net Cash Flow | $-167,831 | $219,740 | $98,371 | $-20,516 | $-14,615 |
| Free Cash Flow | |||||
| Operating Cash Flow | -111,424 | -72,248 | -48,823 | -37,586 | -32,775 |
| Capital Expenditure | -946 | -699 | -476 | -582 | -948 |
| Free Cash Flow | -112,370 | -72,947 | -49,299 | -38,168 | -33,723 |